Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer

被引:5
作者
Papadopoulos, Efthymios [1 ,2 ]
Alibhai, Shabbir M. H. [2 ,3 ,4 ]
Tomlinson, George A. [3 ,4 ,6 ]
Matthew, Andrew G. [3 ,4 ]
Nesbitt, Michael [5 ]
Finelli, Antonio [3 ,5 ]
Trachtenberg, John [3 ,5 ]
Santa Mina, Daniel [1 ,2 ,3 ]
机构
[1] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol, Toronto, ON, Canada
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
Prostate cancer; Low-risk disease; Active surveillance; Physical activity; Treatment; EXERCISE; LIFE;
D O I
10.1007/s10552-019-01211-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Epidemiologic data suggest that high levels of physical activity (PA) may reduce the risk of disease progression in men with prostate cancer (PCa), but it is unknown whether PA can delay the requirement for definitive treatment for those on active surveillance (AS). We investigated the influence of PA post-diagnosis on AS discontinuation in men with low-risk disease. Methods The effect of PA on the time to AS discontinuation was assessed in 421 patients, of whom 107 underwent additional PCa treatment over a median of 2.5 years. Results Using Cox regression models, we found that PA was not significantly associated with time to curative treatment initiation. Prostate-specific antigen (PSA) most proximal to AS initiation (HR, 1.11; 95% CI 1.03 to 1.21) and the number of positive cores (HR, 1.34; 95% CI 1.12 to 1.61) at diagnosis were associated with a significantly increased risk of discontinuing AS. Conclusion Our findings suggest that PA during AS for PCa does not significantly influence time to curative treatment.
引用
收藏
页码:1009 / 1012
页数:4
相关论文
共 50 条
  • [31] Trends in active surveillance for very low-risk prostate cancer: do guidelines influence modern practice?
    Parikh, Rahul R.
    Kim, Sinae
    Stein, Mark N.
    Haffty, Bruce G.
    Kim, Isaac Y.
    Goyal, Sharad
    CANCER MEDICINE, 2017, 6 (10): : 2410 - 2418
  • [32] Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer
    Van Hemelrijck, Mieke
    Garmo, Hans
    Lindhagen, Lars
    Bratt, Ola
    Stattin, Par
    Adolfsson, Jan
    EUROPEAN UROLOGY, 2017, 72 (04) : 534 - 541
  • [33] Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty
    Mader, Emily M.
    Li, Hsin H.
    Lyons, Kathleen D.
    Morley, Christopher P.
    Formica, Margaret K.
    Perrapato, Scott D.
    Irwin, Brian H.
    Seigne, John D.
    Hyams, Elias S.
    Mosher, Terry
    Hegel, Mark T.
    Stewart, Telisa M.
    BMC UROLOGY, 2017, 17 : 1 - 8
  • [34] Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Dall'Era, Marc A.
    Konety, Badrinath R.
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (05): : 277 - 283
  • [35] Can we expand the borders in active surveillance for low-risk prostate cancer?
    Islamoglu, Ekrem
    Kisa, Erdem
    Yucel, Cem
    Celik, Orcun
    Cakmak, Ozgur
    Yalbuzdag, Okan
    Kozacioglu, Zafer
    JOURNAL OF CLINICAL UROLOGY, 2019, 12 (01) : 54 - 59
  • [36] A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer
    Ehdaie, Behfar
    Assel, Melissa
    Benfante, Nicole
    Malhotra, Deepak
    Vickers, Andrew
    EUROPEAN UROLOGY, 2017, 71 (06) : 866 - 871
  • [37] Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer
    Davison, B. Joyce
    Goldenberg, S. Larry
    BJU INTERNATIONAL, 2011, 108 (11) : 1787 - 1793
  • [38] Active Surveillance in Low-Risk Prostate Cancer. Patient Acceptance and Results
    Hernandez, V.
    Blazquez, C.
    de la Pena, E.
    Perez-Fernandez, E.
    Diaz, F. J.
    Llorente, C.
    ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (09): : 533 - 537
  • [39] Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitatspartnerschaft Urologie (QuapU)
    Eredics, Klaus
    Dorfinger, Karl
    Kramer, Gero
    Ponholzer, Anton
    Madersbacher, Stephan
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (11-12) : 375 - 379
  • [40] A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland
    J. C. Forde
    P. J. Daly
    S. White
    M. Morrin
    G. P. Smyth
    B. D. P. O’Neill
    R. E. Power
    Irish Journal of Medical Science (1971 -), 2014, 183 : 377 - 382